« Back
Home /
BAY 59-7939 (Rivaroxaban)

BAY 59-7939 (Rivaroxaban)

Item no.	DCC-DC5108-100mg
Manufacturer	DCChemicals
CASRN	366789-02-8
Amount	100 mg
Quantity options	100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category	Reagents & Chemicals Molecules
Type	Inhibitors
Specific against	other
Purity	>98%
Smiles	C(C(NC[C@H]1OC(=O)N(C2=CC=C(N3CCOCC3=O)C=C2)C1)=O)1SC(Cl)=CC=1
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	366789-02-8
Similar products	366789-02-8
Available
Manufacturer - Applications	Rivaroxaban (Xarelto; BAY 59-7939) is a novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders.
Storage Conditions	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight	435, 88
Note	For research only, not for human use!
Chemical name	5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide; Xarelto

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 11/20/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer